Details of the Drug

General Information of Drug (ID: DMZ0E69)

• Drug Name: AAV-sFLT gene therapy

Indication

Disease Entry	ICD 11	Status	REF
Age-related macular degeneration	9B75.0	Phase 1	[1]

• Cross-matching ID: TTD ID: D0J4CV

References

• [1] ClinicalTrials.gov (NCT00229736) A Study of AAV-hAADC-2 in Subjects With Parkinson's Disease. U.S. National Institutes of Health.